Research is exploring the role of microbiota and adaptive immunity in autoimmune diseases and other conditions, including cancer and atherosclerosis. The gut microbiota is being studied as a potential target for regulating immune responses and improving treatment outcomes. Studies are investigating the complex interactions between the microbiota, immune system, and various diseases, with some focusing on the potential of microbiota-derived metabolites to modulate cancer immunotherapy responses.